AstraZeneca’s (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point

AstraZeneca’s (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.